DR info

Clinical trials : 44 / Drugs : 61 - (DrugBank : 23) / Drug target genes : 57 - Drug target pathways : 83

Rett syndrome and other diseases between which drug repositioning might occur (Sakate and Kimura 2021) . Circle size: Number of drugs, Line breadth: Drug repositionability

ID	Diseases (Sorted by drug repositionability)
156	Rett syndrome
13	Multiple sclerosis/Neuromyelitis optica
2	Amyotrophic lateral sclerosis
96	Crohn disease
6	Parkinson disease
140	Dorabe syndrome
97	Ulcerative colitis
144	Lennox-Gastaut syndrome
8	Huntington disease
193	Prader-Willi syndrome
206	Fragile X syndrome
5	Progressive supranuclear palsy
18	Spinocerebellar degeneration
17	Multiple system atrophy
3	Spinal muscular atrophy
70	Spinal stenosis
298	Hereditary pancreatitis
205	Fragile X syndrome related disease
46	Malignant rheumatoid arthritis
21	Mitochondrial disease
272	Fibrodysplasia ossificans progressiva
145	West syndrome
152	PCDH19 related syndrome
98	Eosinophilic gastrointestinal disease
231	Alpha-1-antitrypsin deficiency
36	Epidermolysis bullosa
203	22q11.2 deletion syndrome
201	Angelman syndrome
296	Biliary atresia
155	Acquired aphasia with convulsive disorder
158	Tuberous sclerosis
84	Sarcoidosis
34	Neurofibromatosis
22	Moyamoya disease
226	Interstitial cystitis with Hunners ulcer
86	Pulmonary arterial hypertension
75	Cushing disease
127	Frontotemporal lobar degeneration
113	Muscular dystrophy
299	Cystic fibrosis
58	Hypertrophic cardiomyopathy
114	Non-dystrophic myotonia syndrome
254	Porphyria
51	Scleroderma
168	Ehlers-Danlos syndrome
53	Sjogren syndrome
78	Hypopituitarism
1	Spinal and bulbar muscular atrophy
10	Charcot-Marie-Tooth disease
4	Primary lateral sclerosis
120	Hereditary dystonia
179	Williams syndrome
38	Stevens-Johnson syndrome
167	Marfan syndrome
49	Systemic lupus erythematosus
215	Tetralogy of Fallot
90	Retinitis pigmentosa
256	Muscle glycogenosis
81	Congenital adrenal hyperplasia
187	Kabuki syndrome
50	Dermatomyositis
149	Hemiconvulsion hemiplegia epilepsy syndrome
85	Idiopathic interstitial pneumonia